Kinney Drugs Scales Back AI Assistant After Dosage Errors, Restores Touch-Tone Calls
Updated
Updated · WCAX · Aug 7
Kinney Drugs Scales Back AI Assistant After Dosage Errors, Restores Touch-Tone Calls
1 articles · Updated · WCAX · Aug 7
Summary
Kinney Drugs is pulling back Burt from incoming patient calls and reverting to its older touch-tone phone system after complaints about the AI assistant.
Customers reported incoherent calls, wrong dosage information and missed prescription notifications after Burt was introduced in May to handle prescription and refill communications.
John Marraffa, the chain’s president, said the company got the customer experience wrong, even as it maintained Burt is HIPAA-compliant, not open-source and does not generate or manipulate data.
Burt will remain in limited use for outbound messages such as refill texts, but patients will have to opt in as privacy concerns around health information persist.